Impact of Adherence to Anemia Management Policy on Repeat Hospitalization in End Stage Renal Disease (ESRD)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Raymond Hakim, M.D., Ph.D.
Fresenius Medical Services
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
42 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Denver Central
Denver, Colorado, United States
- Jax Beach
Jacksonville, Florida, United States
- St. John'S
Jacksonville, Florida, United States
- Prairie
Chicago, Illinois, United States
- Tri Counties
Decatur, Indiana, United States
- Huntington
Huntington, Indiana, United States
- Floyd County
New Albany, Indiana, United States
- South Louisville
Louisville, Kentucky, United States
- Breaux Bridge
Breaux Bridge, Louisiana, United States
- Delta
Delta, Louisiana, United States
- East Lafayette
Lafayette, Louisiana, United States
- Methuen
Methuen, Massachusetts, United States
- Roxbury
Roxbury, Massachusetts, United States
- Battle Creek
Battle Creek, Michigan, United States
- East Lansing
East Lansing, Michigan, United States
- Oshtemo
Kalamazoo, Michigan, United States
- Lansing
Lansing, Michigan, United States
- Saganaw Riverside
Saginaw, Michigan, United States
- Saginaw
Saginaw, Michigan, United States
- Eupora
Eupora, Mississippi, United States
- Meridian
Meridian, Mississippi, United States
- Yokna River
Oxford, Mississippi, United States
- Independence Centerpoint
Independence, Missouri, United States
- Desert Inn
Las Vegas, Nevada, United States
- South Pecos
Las Vegas, Nevada, United States
- Briggs Ave
Durham, North Carolina, United States
- Freedom Lake
Durham, North Carolina, United States
- Boardman
Boardman, Ohio, United States
- Cortland
Cortland, Ohio, United States
- Elyria
Elyria, Ohio, United States
- North Randall
North Randall, Ohio, United States
- Westlake
Westlake, Ohio, United States
- Willoughby
Willoughby, Ohio, United States
- Twin Oaks
Beaverton, Oregon, United States
- Clackamas
Clackamas, Oregon, United States
- Fresenius Medical Services
Brentwood, Tennessee, United States
- Smyrna
Smyrna, Tennessee, United States
- West Nashville
West Nashville, Tennessee, United States
- North Fort Worth
Fort Worth, Texas, United States
- Tarrant County
Fort Worth, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2009
- Primary completion
- 30 Nov 2010
- Completion
- 31 Dec 2010
- Last update posted
- 2 Apr 2010
- Registered enrollment
- 1,500
- Registry id
- NCT01017627
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.